Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-005021·Woodline Partners LP
Schedule 13G ownership disclosure
Zevra Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 488445206
Event date: 2025-09-30
- Filing-level shares
- 3,476,143.00
- Percent of class
- 6.2%
- Woodline Partners LP
Shares: 3,476,143.00 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005021
- Form type
- SCHEDULE 13G/A
- Filer
- Woodline Partners LP
- CIK
- CIK 1784547
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership